V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330009548 | 330007774 | 1.57 | null | Adjuvant (A) | 2016-06-08 | 2016-06-23 | CISPLATIN + RT | N | Y | 330002686 | CISPLATIN + RT |
| 330009549 | 330010235 | 0 | 14 | Neo-adjuvant (N) | null | 2016-03-28 | EW EuroEwing 2012 Arm B VC | N | N | 330002705 | NOT MATCHED |
| 330009550 | 330003332 | 1.35 | 52 | null | 2014-07-01 | 2014-07-08 | NB HRNBL-1 COJEC Ind COURSE B | 02 | N | 330002707 | NOT MATCHED |
| 330009551 | 330003334 | 0.98 | 11.2 | Curative (C) | 2015-04-13 | 2015-04-15 | EW EuroEwing 2012 Arm A/B Zol Acid | null | Y | 330002732 | NOT MATCHED |
| 330009552 | 330007779 | 1.7 | null | Not known (9) | 2015-07-02 | 2015-07-27 | CISPLATIN + RT | null | Y | 330002743 | CISPLATIN + RT |
| 330009553 | 330003340 | null | 9.3 | Neo-adjuvant (N) | 2017-01-10 | 2017-01-17 | NB Rel CCLG guidelines Cyclo-Topotecan | N | N | 330002747 | NOT MATCHED |
| 330009554 | 330003340 | 1.75 | 73.6 | null | 2017-07-26 | 2017-08-22 | Cisplatin + Radiotherapy | N | N | 330002747 | CISPLATIN + RT |
| 330009555 | 330003341 | null | null | Curative (C) | null | 2016-09-15 | CISPLATIN + RT | 02 | null | 330002762 | CISPLATIN + RT |
| 330009556 | 330007783 | 1.79 | 64.6 | Curative (C) | 2016-10-18 | 2016-10-25 | Cisplatin + Radiotherapy | null | null | 330002800 | CISPLATIN + RT |
| 330009557 | 330003345 | 1.63 | 55.4 | Curative (C) | null | 2014-11-28 | Cisplatin + Radiotherapy | 02 | Y | 330002809 | CISPLATIN + RT |
| 330009558 | 330003346 | null | null | null | 2014-02-11 | 2014-02-18 | NB HRNBL-1 Isotretinoin | N | N | 330002811 | NOT MATCHED |
| 330009559 | 330003347 | 0.78 | 33.4 | Curative (C) | 2017-01-08 | 2017-01-16 | LCHIV | 02 | N | 330002816 | NOT MATCHED |
| 330009560 | 330007786 | null | 21.6 | Curative (C) | 2017-11-05 | 2018-05-09 | NB HRNBL-1 COJEC Ind COURSE C | 01 | N | 330002818 | NOT MATCHED |
| 330009561 | 330003351 | 0 | 11.6 | Neo-adjuvant (N) | 2014-03-02 | 2014-06-23 | NB BEACON Temozolomide Irinotecan | N | Y | 330002830 | NOT MATCHED |
| 330009562 | 330003352 | 1.82 | 24 | Curative (C) | 2016-05-06 | 2016-05-06 | CNS LGG 2004 03 cons vinc + carbo | null | N | 330002835 | NOT MATCHED |
| 330009563 | 330003355 | null | 82.5 | Curative (C) | 2016-02-28 | 2016-05-04 | CISPLATIN + RT | N | null | 330002838 | CISPLATIN + RT |
| 330009564 | 330003357 | null | 54 | null | 2016-04-14 | 2017-04-10 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330002844 | CISPLATIN + RT |
| 330009565 | 330003357 | 1.74 | null | Curative (C) | 2016-10-02 | 2016-10-02 | Cisplatin + Radiotherapy | N | N | 330002844 | CISPLATIN + RT |
| 330009566 | 330003363 | 1.47 | 15 | Curative (C) | 2016-07-08 | 2016-07-15 | NB HRNBL-1 ch14.18/CHO only (trial) | null | N | 330002879 | NOT MATCHED |
| 330009567 | 330003364 | 0 | 12.05 | Palliative (P) | null | 2015-04-03 | NB HRNBL-1 Isotretinoin | Y | null | 330002884 | NOT MATCHED |
| 330009568 | 330003369 | 0 | 12.5 | Palliative (P) | 2013-04-10 | 2013-07-30 | EW EuroEwing 2012 Arm B VC | N | N | 330002909 | NOT MATCHED |
| 330009569 | 330003371 | 1.86 | 88.8 | Curative (C) | 2016-09-15 | 2016-10-10 | Cisplatin 100 + RT(H&N) 1 day | N | N | 330002931 | CISPLATIN + RT |
| 330009570 | 330003373 | null | 12.1 | Neo-adjuvant (N) | 2018-10-13 | 2018-10-25 | NB HRNBL-1 TVD | null | null | 330002942 | NOT MATCHED |
| 330009571 | 330003374 | null | 55.8 | Adjuvant (A) | 2018-01-13 | 2018-02-28 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 330002944 | CISPLATIN + RT |
| 330009572 | 330003377 | 1.85 | null | Curative (C) | 2015-07-13 | 2015-08-08 | CISPLATIN + RT | 02 | N | 330002960 | CISPLATIN + RT |
| 330009575 | 330003380 | null | 55.5 | Curative (C) | 2014-02-22 | 2014-03-22 | Cisplatin + Radiotherapy | null | null | 330002979 | CISPLATIN + RT |
| 330009576 | 330003382 | 0 | 52.2 | Curative (C) | 2016-10-12 | 2016-11-03 | CNS GCT II Germinoma - Ifos Etop | Y | N | 330002981 | NOT MATCHED |
| 330009577 | 330003386 | 0.92 | 59.1 | Curative (C) | 2018-05-23 | 2018-06-20 | NB HRNBL-1 COJEC Ind COURSE A | N | null | 330002986 | NOT MATCHED |
| 330009578 | 330003387 | null | null | Curative (C) | 2015-09-10 | 2016-03-07 | NB HRNBL-1 COJEC Ind COURSE B | Y | N | 330002991 | NOT MATCHED |
| 330009579 | 330003387 | null | 35.7 | Disease modification (D) | 2014-06-29 | 2014-07-04 | AML MyeChild 01 FLA-Idarubicin | N | null | 330002991 | NOT MATCHED |
| 330009580 | 330003390 | null | 22.5 | Curative (C) | 2015-02-17 | 2015-03-01 | NB HRNBL-1 ch14.18/CHO only (trial) | N | N | 330003007 | NOT MATCHED |
| 330009581 | 330003391 | 0 | 36.35 | Curative (C) | 2015-03-13 | 2017-12-07 | EW Rel rEECur Gemcitabine/Docetaxel + GCSF | 02 | N | 330003010 | NOT MATCHED |
| 330009582 | 330007806 | 1.72 | 82 | Disease modification (D) | 2014-01-20 | 2014-02-16 | Cisplatin 100 + RT(H&N) 1 day | N | Y | 330003012 | CISPLATIN + RT |
| 330009583 | 330003394 | 1.55 | 78.2 | Curative (C) | 2016-01-29 | 2016-02-27 | Cisplatin 100 + RT(H&N) 1 day | 02 | N | 330003016 | CISPLATIN + RT |
| 330009584 | 330003396 | 1.5 | 50.4 | Not known (9) | 2017-02-13 | 2017-09-10 | Cisplatin + Radiotherapy | 02 | Y | 330003017 | CISPLATIN + RT |
| 330009585 | 330003398 | 1.76 | 64 | Curative (C) | 2016-02-25 | 2016-07-14 | Cisplatin + Radiotherapy | N | Y | 330003019 | CISPLATIN + RT |
| 330009586 | 330003399 | null | 25.5 | Palliative (P) | 2017-05-16 | 2017-05-22 | NB BEACON Temozolomide Irinotecan | N | N | 330003028 | NOT MATCHED |
| 330009587 | 330003402 | 1.78 | 91.9 | Not known (9) | 2015-07-15 | 2015-07-21 | Cisplatin + Radiotherapy | N | Y | 330003042 | CISPLATIN + RT |
| 330009588 | 330010251 | null | 93.7 | Curative (C) | 2015-12-14 | 2015-12-25 | NB Rel CCLG guidelines Cyclo-Topotecan | Y | N | 330003049 | NOT MATCHED |
| 330009590 | 330003406 | 0 | 7.4 | Palliative (P) | 2017-09-14 | 2017-12-22 | CNS LGG 2004 03 cons vinc +cyclo | N | null | 330003069 | NOT MATCHED |
| 330009591 | 330003407 | 1.15 | 17 | Curative (C) | 2014-11-18 | 2015-01-14 | ALL Interfant 06 Protocol 1B | N | null | 330003076 | NOT MATCHED |
| 330009592 | 330003410 | null | 9.8 | Curative (C) | 2013-11-24 | 2013-11-27 | NB HRNBL-1 Isotretinoin | N | N | 330003086 | NOT MATCHED |
| 330009593 | 330012336 | 0 | 7.2 | Curative (C) | null | 2015-12-24 | CNS GCT II Germinoma - Ifos Etop | N | N | 330003127 | NOT MATCHED |
| 330009594 | 330003412 | 0 | 12.7 | Palliative (P) | 2017-05-28 | 2017-05-28 | null | N | N | 330003144 | NOT MATCHED |
| 330009595 | 330003414 | null | 15.3 | Curative (C) | 2013-06-19 | 2013-06-26 | NB HRNBL-1 BUMEL MAT | 2 | N | 330003157 | NOT MATCHED |
| 330009596 | 330003416 | null | 12.5 | Palliative (P) | 2016-04-23 | 2016-07-31 | NB HRNBL-1 TVD | 02 | N | 330003163 | NOT MATCHED |
| 330009597 | 330007818 | 1.59 | 69 | null | 2016-08-25 | 2016-08-28 | Cisplatin + Radiotherapy | 02 | N | 330003174 | CISPLATIN + RT |
| 330009598 | 330003419 | 0.99 | 7.6 | Palliative (P) | 2018-02-28 | 2018-02-28 | NB HRNBL-1 COJEC Ind COURSE B | N | null | 330003181 | NOT MATCHED |
| 330009599 | 330007820 | 0 | 44.2 | Curative (C) | 2015-02-25 | 2015-03-04 | EW Rel rEECur Gemcitabine/Docetaxel | 02 | N | 330003184 | NOT MATCHED |
| 330009600 | 330003422 | null | 13.2 | Disease modification (D) | null | 2014-01-03 | NB HRNBL-1 COJEC Ind COURSE C | N | N | 330003202 | NOT MATCHED |